These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 641265)

  • 1. Effects of tolerogenic conjugates in a canine model for reaginic hypersensitivity. I. suppression of hapten-specific IgE antibody response.
    Tse KS; Kepron W; Sehon A
    J Allergy Clin Immunol; 1978 May; 61(5):303-9. PubMed ID: 641265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of reaginic antibodies].
    Sehon AH; Lee WY
    Ann Immunol (Paris); 1977; 128(1-2):457-68. PubMed ID: 848899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
    Lee WY; Sehon AH
    J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of reaginic antibody formation. I. Induction of hapten-specific tolerance.
    Lee WY; Sehon AH
    J Immunol; 1975 Feb; 114(2 pt 2):829-36. PubMed ID: 46252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of reaging antibody formation. IV. Suppression of reaginic antibodies to penicillin in the mouse.
    Lee WY; Sehon AH
    J Immunol; 1976 Sep; 117(3):927-34. PubMed ID: 60452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific suppression of anti-hapten reaginic antibody titers with hapten-coated liposomes.
    Schwenk R; Lee WY; Sehon AH
    J Immunol; 1978 May; 120(5):1612-5. PubMed ID: 659865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of reaginic antibody formation. II. The use of adoptive transfer system for the study of immunological unresponsiveness.
    Lee WY; Sehon AH
    J Immunol; 1975 Feb; 114(2 pt 2):837-42. PubMed ID: 46253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol.
    Lee WY; Sechon AH
    Int Arch Allergy Appl Immunol; 1978; 56(3):193-206. PubMed ID: 621116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A canine model for the study of allergic asthma and suppression of hapten-specific IgE antibody response.
    Tse KS; Kepron W; Sehon AH
    Monogr Allergy; 1979; 14():38-44. PubMed ID: 91961
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on the bridging hypothesis of anaphylaxis: haptenic determinants required to elicit immediate-type reactions in calf skin by separate or concurrent sensitization with reagins of different specificity.
    Mossmann H; Meyer-Delius M; Vortisch U; Kickhöfen B; Hammer DK
    J Exp Med; 1974 Dec; 140(6):1468-81. PubMed ID: 4139229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates.
    Katz DH; Davie JM; Paul WE; Benacerraf B
    J Exp Med; 1971 Jul; 134(1):201-23. PubMed ID: 4397662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A canine model for the study of hapten-specific suppression of IgE-mediated bronchoconstriction and anaphylaxis.
    Kepron W; Jackson CJ; Sehon AH
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):468-70. PubMed ID: 3570515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the anti-DNP IgE response with tolerogenic conjugates of DNP with polyvinyl alcohol. I. Specific suppression of the anti-DNP IgE response.
    Hubbard DA; Lee WY; Sehon AH
    J Immunol; 1981 Feb; 126(2):407-13. PubMed ID: 7005336
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of the anti-DNP IgE response with tolerogenic conjugates of DNP with polyvinyl alcohol. II. Induction of hapten-specific suppressor T cells.
    Lee WY; Sehon AH
    J Immunol; 1981 Feb; 126(2):414-8. PubMed ID: 6450243
    [No Abstract]   [Full Text] [Related]  

  • 15. A canine model for reaginic hypersensitivity and allergic bronchoconstriction.
    Kepron W; James JM; Kirk B; Sehon AH; Tse KS
    J Allergy Clin Immunol; 1977 Jan; 59(1):64-9. PubMed ID: 833375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific suppression of the reaginic antibody response.
    Lee WY; Sehon AH
    Monogr Allergy; 1979; 14():86-91. PubMed ID: 91966
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaginic antibody formation in the mouse. V. Adoptive antihapten IgE antibody response of dinitrophenyl-keyhole limpet hemocyanin-primed spleen cells cultured with dinitrophenyl heterologous carrier conjugates.
    Okudaira H; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):615-20. PubMed ID: 47357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaginic antibody formation in the mouse. X. Possible role of suppressor T cells in transient IgE antibody responses.
    Tamura SI; Ishizaka K
    J Immunol; 1978 Mar; 120(3):837-43. PubMed ID: 305447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxymethyl cellulose, a nonimmunogenic hapten carrier with tolerogenic properties.
    Diner UE; Kunimoto D; Diener E
    J Immunol; 1979 May; 122(5):1886-91. PubMed ID: 312854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological tolerance in bone marrow-derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells.
    Katz DH; Hamaoka T; Benacerraf B
    J Exp Med; 1972 Dec; 136(6):1404-29. PubMed ID: 4539311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.